Skip to main content

Lewis William's Form 4 filing

INSMED Inc (INSM) · filed Apr 8, 2026

Accession no.
0001402051-26-000022
Filed
Apr 8, 2026
Trade date
Apr 6, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.75M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Lewis WilliamCIK 0001402051Director, Officer (Chair and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 6, 2026Common StockMOption exerciseAcquired+6,259$30.46+$190,649.14307,444Direct
Apr 6, 2026Common StockMOption exerciseAcquired+4,440$17.16+$76,190.4311,884Direct
Apr 6, 2026Common StockSSaleDisposed−787$161.73F2−$127,281.51311,097Direct
Apr 6, 2026Common StockSSaleDisposed−8,478$163.23F3−$1,383,863.94302,619Direct
Apr 6, 2026Common StockSSaleDisposed−1,434$164.01F4−$235,190.34301,185Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 6, 2026Common StockMOption exerciseDisposed−6,259$0.00$043,814Direct
Apr 6, 2026Common StockMOption exerciseDisposed−4,440$0.00$031,080Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This is the weighted average sales price representing 787 shares sold at prices ranging from $161.65 to $162.58 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Referenced by the price of 1 transaction in Table I.

F3

This is the weighted average sales price representing 8,478 shares sold at prices ranging from $162.66 to $163.65 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Referenced by the price of 1 transaction in Table I.

F4

This is the weighted average sales price representing 1,434 shares sold at prices ranging from $163.66 to $164.36 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)